Skip to main content
Top
Published in: The International Journal of Cardiovascular Imaging 3/2018

01-03-2018 | Original Paper

Gated thoracic magnetic resonance angiography at 3T: noncontrast versus blood pool contrast

Authors: Chengcheng Zhu, Henrik Haraldsson, Kimberly Kallianos, Liang Ge, Elaine Tseng, Travis Henry, David Saloner, Michael D. Hope

Published in: The International Journal of Cardiovascular Imaging | Issue 3/2018

Login to get access

Abstract

Both noncontrast and contrast-enhanced approaches to gated thoracic magnetic resonance angiography (MRA) for aortic root evaluation have been reported at 3T. We compare qualitative and quantitative image quality measures for the two approaches, and assess the reproducibility of standard aortic measurements. Respiratory and cardiac gated MRA of the chest was performed at 3T in 45 patients: 23 after administration of iron-based blood pool contrast, and 22 without contrast. Image quality was assessed with a 5-point Likert scale, vessel lumen-to-muscle contrast ratios, and vessel wall sharpness. Two reviewers measured the ascending aorta diameter and valve annulus area. Interrater agreement was assessed using Bland–Altman plots and coefficient of variation (CV). Qualitative image quality was better with blood pool contrast in all principal vessels of the chest (mean Likert of 4.20 ± 0.79 vs. 2.60 ± 0.77, p < 0.001). Quantitative assessment was also improved with higher contrast ratios in all vessels (5.26 ± 3.3 vs. 1.90 ± 0.53, p < 0.001), and greater sharpness of the aortic annulus and ascending aorta (0.70 ± 0.16 vs. 0.56 ± 0.14 mm−1, p < 0.001, and 0.87 ± 0.16 vs. 0.62 ± 0.16 mm−1, p = 0.008, respectively). Reproducibility of measurement was marginally better for the ascending aorta diameter (CV of 2.80 vs. 3.23%), but substantially increased for the aortic valve annulus area with blood pool contrast (CV of 4.93 vs. 7.32%). The use of a blood pool contrast agent for gated thoracic MRA improves image quality compared to a noncontrast technique, and provides more reproducible measurements of the aortic valve annulus area.
Literature
1.
go back to reference Jilaihawi H, Kashif M, Fontana G, Furugen A, Shiota T, Friede G, Makhija R, Doctor N, Leon MB, Makkar RR (2012) Cross-sectional computed tomographic assessment improves accuracy of aortic annular sizing for transcatheter aortic valve replacement and reduces the incidence of paravalvular aortic regurgitation. J Am Coll Cardiol 59(14):1275–1286. doi:10.1016/j.jacc.2011.11.045 CrossRefPubMed Jilaihawi H, Kashif M, Fontana G, Furugen A, Shiota T, Friede G, Makhija R, Doctor N, Leon MB, Makkar RR (2012) Cross-sectional computed tomographic assessment improves accuracy of aortic annular sizing for transcatheter aortic valve replacement and reduces the incidence of paravalvular aortic regurgitation. J Am Coll Cardiol 59(14):1275–1286. doi:10.​1016/​j.​jacc.​2011.​11.​045 CrossRefPubMed
2.
go back to reference Binder RK, Webb JG, Toggweiler S, Freeman M, Barbanti M, Willson AB, Alhassan D, Hague CJ, Wood DA, Leipsic J (2013) Impact of post-implant SAPIEN XT geometry and position on conduction disturbances, hemodynamic performance, and paravalvular regurgitation. JACC Cardiovasc Interv 6(5):462–468. doi:10.1016/j.jcin.2012.12.128 CrossRefPubMed Binder RK, Webb JG, Toggweiler S, Freeman M, Barbanti M, Willson AB, Alhassan D, Hague CJ, Wood DA, Leipsic J (2013) Impact of post-implant SAPIEN XT geometry and position on conduction disturbances, hemodynamic performance, and paravalvular regurgitation. JACC Cardiovasc Interv 6(5):462–468. doi:10.​1016/​j.​jcin.​2012.​12.​128 CrossRefPubMed
3.
go back to reference Athappan G, Patvardhan E, Tuzcu EM, Svensson LG, Lemos PA, Fraccaro C, Tarantini G, Sinning JM, Nickenig G, Capodanno D, Tamburino C, Latib A, Colombo A, Kapadia SR (2013) Incidence, predictors, and outcomes of aortic regurgitation after transcatheter aortic valve replacement: meta-analysis and systematic review of literature. J Am Coll Cardiol 61(15):1585–1595. doi:10.1016/j.jacc.2013.01.047 CrossRefPubMed Athappan G, Patvardhan E, Tuzcu EM, Svensson LG, Lemos PA, Fraccaro C, Tarantini G, Sinning JM, Nickenig G, Capodanno D, Tamburino C, Latib A, Colombo A, Kapadia SR (2013) Incidence, predictors, and outcomes of aortic regurgitation after transcatheter aortic valve replacement: meta-analysis and systematic review of literature. J Am Coll Cardiol 61(15):1585–1595. doi:10.​1016/​j.​jacc.​2013.​01.​047 CrossRefPubMed
4.
go back to reference Kodali SK, Williams MR, Smith CR, Svensson LG, Webb JG, Makkar RR, Fontana GP, Dewey TM, Thourani VH, Pichard AD, Fischbein M, Szeto WY, Lim S, Greason KL, Teirstein PS, Malaisrie SC, Douglas PS, Hahn RT, Whisenant B, Zajarias A, Wang D, Akin JJ, Anderson WN, Leon MB, Investigators PT (2012) Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med 366(18):1686–1695. doi:10.1056/NEJMoa1200384 CrossRefPubMed Kodali SK, Williams MR, Smith CR, Svensson LG, Webb JG, Makkar RR, Fontana GP, Dewey TM, Thourani VH, Pichard AD, Fischbein M, Szeto WY, Lim S, Greason KL, Teirstein PS, Malaisrie SC, Douglas PS, Hahn RT, Whisenant B, Zajarias A, Wang D, Akin JJ, Anderson WN, Leon MB, Investigators PT (2012) Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med 366(18):1686–1695. doi:10.​1056/​NEJMoa1200384 CrossRefPubMed
5.
go back to reference Thourani VH, Keeling WB, Sarin EL, Guyton RA, Kilgo PD, Dara AB, Puskas JD, Chen EP, Cooper WA, Vega JD, Morris CD, Halkos ME, Lattouf OM (2011) Impact of preoperative renal dysfunction on long-term survival for patients undergoing aortic valve replacement. Ann Thorac Surg 91(6):1798–1806. doi:10.1016/j.athoracsur.2011.02.015.CrossRefPubMed Thourani VH, Keeling WB, Sarin EL, Guyton RA, Kilgo PD, Dara AB, Puskas JD, Chen EP, Cooper WA, Vega JD, Morris CD, Halkos ME, Lattouf OM (2011) Impact of preoperative renal dysfunction on long-term survival for patients undergoing aortic valve replacement. Ann Thorac Surg 91(6):1798–1806. doi:10.​1016/​j.​athoracsur.​2011.​02.​015.CrossRefPubMed
6.
go back to reference von Knobelsdorff-Brenkenhoff F, Gruettner H, Trauzeddel RF, Greiser A, Schulz-Menger J (2014) Comparison of native high-resolution 3D and contrast-enhanced MR angiography for assessing the thoracic aorta. Eur Heart J Cardiovasc Imaging 15(6):651–658. doi:10.1093/ehjci/jet263 CrossRef von Knobelsdorff-Brenkenhoff F, Gruettner H, Trauzeddel RF, Greiser A, Schulz-Menger J (2014) Comparison of native high-resolution 3D and contrast-enhanced MR angiography for assessing the thoracic aorta. Eur Heart J Cardiovasc Imaging 15(6):651–658. doi:10.​1093/​ehjci/​jet263 CrossRef
7.
go back to reference Ruile P, Blanke P, Krauss T, Dorfs S, Jung B, Jander N, Leipsic J, Langer M, Neumann FJ, Pache G (2016) Pre-procedural assessment of aortic annulus dimensions for transcatheter aortic valve replacement: comparison of a non-contrast 3D MRA protocol with contrast-enhanced cardiac dual-source CT angiography. Eur Heart J Cardiovasc Imaging 17(4):458–466. doi:10.1093/ehjci/jev188 CrossRefPubMed Ruile P, Blanke P, Krauss T, Dorfs S, Jung B, Jander N, Leipsic J, Langer M, Neumann FJ, Pache G (2016) Pre-procedural assessment of aortic annulus dimensions for transcatheter aortic valve replacement: comparison of a non-contrast 3D MRA protocol with contrast-enhanced cardiac dual-source CT angiography. Eur Heart J Cardiovasc Imaging 17(4):458–466. doi:10.​1093/​ehjci/​jev188 CrossRefPubMed
10.
go back to reference Groves EM, Bireley W, Dill K, Carroll TJ, Carr JC (2007) Quantitative analysis of ECG-gated high-resolution contrast-enhanced MR angiography of the thoracic aorta. AJR Am J Roentgenol 188(2):522–528. doi:10.2214/AJR.05.1467 CrossRefPubMed Groves EM, Bireley W, Dill K, Carroll TJ, Carr JC (2007) Quantitative analysis of ECG-gated high-resolution contrast-enhanced MR angiography of the thoracic aorta. AJR Am J Roentgenol 188(2):522–528. doi:10.​2214/​AJR.​05.​1467 CrossRefPubMed
11.
go back to reference Sinning JM, Ghanem A, Steinhauser H, Adenauer V, Hammerstingl C, Nickenig G, Werner N (2010) Renal function as predictor of mortality in patients after percutaneous transcatheter aortic valve implantation. JACC Cardiovasc Interv 3(11):1141–1149. doi:10.1016/j.jcin.2010.09.009 CrossRefPubMed Sinning JM, Ghanem A, Steinhauser H, Adenauer V, Hammerstingl C, Nickenig G, Werner N (2010) Renal function as predictor of mortality in patients after percutaneous transcatheter aortic valve implantation. JACC Cardiovasc Interv 3(11):1141–1149. doi:10.​1016/​j.​jcin.​2010.​09.​009 CrossRefPubMed
12.
go back to reference Jabbour A, Ismail TF, Moat N, Gulati A, Roussin I, Alpendurada F, Park B, Okoroafor F, Asgar A, Barker S, Davies S, Prasad SK, Rubens M, Mohiaddin RH (2011) Multimodality imaging in transcatheter aortic valve implantation and post-procedural aortic regurgitation: comparison among cardiovascular magnetic resonance, cardiac computed tomography, and echocardiography. J Am Coll Cardiol 58(21):2165–2173. doi:10.1016/j.jacc.2011.09.010 CrossRefPubMed Jabbour A, Ismail TF, Moat N, Gulati A, Roussin I, Alpendurada F, Park B, Okoroafor F, Asgar A, Barker S, Davies S, Prasad SK, Rubens M, Mohiaddin RH (2011) Multimodality imaging in transcatheter aortic valve implantation and post-procedural aortic regurgitation: comparison among cardiovascular magnetic resonance, cardiac computed tomography, and echocardiography. J Am Coll Cardiol 58(21):2165–2173. doi:10.​1016/​j.​jacc.​2011.​09.​010 CrossRefPubMed
13.
go back to reference La Manna A, Sanfilippo A, Capodanno D, Salemi A, Polizzi G, Deste W, Cincotta G, Cadoni A, Marchese A, Figuera M, Ussia GP, Pittala R, Privitera C, Tamburino C (2011) Cardiovascular magnetic resonance for the assessment of patients undergoing transcatheter aortic valve implantation: a pilot study. J Cardiovasc Magn Res 13:82. doi:10.1186/1532-429X-13-82 CrossRef La Manna A, Sanfilippo A, Capodanno D, Salemi A, Polizzi G, Deste W, Cincotta G, Cadoni A, Marchese A, Figuera M, Ussia GP, Pittala R, Privitera C, Tamburino C (2011) Cardiovascular magnetic resonance for the assessment of patients undergoing transcatheter aortic valve implantation: a pilot study. J Cardiovasc Magn Res 13:82. doi:10.​1186/​1532-429X-13-82 CrossRef
14.
go back to reference Prince MR, Zhang HL, Chabra SG, Jacobs P, Wang Y (2003) A pilot investigation of new superparamagnetic iron oxide (ferumoxytol) as a contrast agent for cardiovascular MRI. J X-ray Sci Technol 11(4):231–240 Prince MR, Zhang HL, Chabra SG, Jacobs P, Wang Y (2003) A pilot investigation of new superparamagnetic iron oxide (ferumoxytol) as a contrast agent for cardiovascular MRI. J X-ray Sci Technol 11(4):231–240
15.
16.
go back to reference Vasanawala SS, Nguyen KL, Hope MD, Bridges MD, Hope TA, Reeder SB, Bashir MR (2016) Safety and technique of ferumoxytol administration for MRI. Magn Res Med 75(5):2107–2111. doi:10.1002/mrm.26151 CrossRef Vasanawala SS, Nguyen KL, Hope MD, Bridges MD, Hope TA, Reeder SB, Bashir MR (2016) Safety and technique of ferumoxytol administration for MRI. Magn Res Med 75(5):2107–2111. doi:10.​1002/​mrm.​26151 CrossRef
Metadata
Title
Gated thoracic magnetic resonance angiography at 3T: noncontrast versus blood pool contrast
Authors
Chengcheng Zhu
Henrik Haraldsson
Kimberly Kallianos
Liang Ge
Elaine Tseng
Travis Henry
David Saloner
Michael D. Hope
Publication date
01-03-2018
Publisher
Springer Netherlands
Published in
The International Journal of Cardiovascular Imaging / Issue 3/2018
Print ISSN: 1569-5794
Electronic ISSN: 1875-8312
DOI
https://doi.org/10.1007/s10554-017-1242-8

Other articles of this Issue 3/2018

The International Journal of Cardiovascular Imaging 3/2018 Go to the issue